Arcobacter butzleri and intestinal colonization

Jiménez‐Guerra, Gemma; MorenoTorres, I Casanovas; Moldovan, Tabitha; Navarro-Marí, José María; Gutiérrez‐Fernández, José

doi:10.37201/req/060.2019

Cited by 7 publications

(9 citation statements)

References 16 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Candida glabrata is a pathogenic agent in humans. This opportunistic fungus accounts for up to 29% of total bloodstream infections, in addition to causing infections of the urinary tract and vagina 11,12 , recognized as important causes of morbidity and mortality, especially in immunosuppressed patients [11][12][13] . Some of the risk factors for urinary tract infections by Candida species are immunosuppression, diabetes mellitus, prolonged hospitalization, urinary catheter, use of broad-spectrum antibiotics, female gender, and age over 65 11.12 .…”

Section: Discussionmentioning

confidence: 99%

Actinic cystitis associated with urinary tract infection by Candida glabrata as a differential diagnosis of pudendal neuralgia. Case report

Hoffmann¹,

Daronco²,

Seyboth³

2020

Brazilian Journal of Pain

View full text Add to dashboard Cite

BACKGROUND AND OBJECTIVES: Chronic pelvic pain is still a little-known syndrome with different etiological agents, high morbidity rate, with little information about its etiopathogenesis, which makes its treatment difficult, with symptoms that significantly impact the patient's quality of life. Among the conditions that lead to chronic pelvic pain, actinic cystitis stands out, a complication of pelvic radiotherapy. This pathology presents signs, symptoms, and complications similar to pudendal neuralgia. The objective of this report is to present one of the etiologies of chronic pelvic pain and its treatment. CASE REPORT: Sixty-three-year-old male patient who sought medical care with a history of chronic pelvic pain attributed to pudendal neuralgia. The diagnosis was actinic cystitis, resulting from pelvic radiotherapy for prostate adenocarcinoma and urinary tract infection by Candida glabrata, an opportunistic fungal agent. The patient was treated with fluconazole with total control of the painful symptoms and significant improvement in the quality of life. CONCLUSION: A case report with total pain control in a patient with an initial diagnosis of pudendal neuralgia, who after the clinical evaluation, imaging tests, cystoscopy, and lab tests was diagnosed with actinic cystitis associated to the urinary tract infection by Candida glabrata.

show abstract

Section: Discussionmentioning

confidence: 99%

Actinic cystitis associated with urinary tract infection by Candida glabrata as a differential diagnosis of pudendal neuralgia. Case report

Hoffmann¹,

Daronco²,

Seyboth³

2020

Brazilian Journal of Pain

View full text Add to dashboard Cite

show abstract

“…Усиление колонизации мочевых путей грибами происходит при наличии мочевого дренажа, конкремента в мочевых путях и после антибактериальной терапии [4,10,12,16,35]. Однако влияние антибактериальной терапии как единственного фактора риска усиления колонизации грибами Candida у женщин с неосложненной ИМП не подтвердилось в исследовании R.M.…”

Section: факторы риска кандидоза мочевыводящих путейunclassified

“…В 83-90% случаев кандидурия возникает у пациентов с мочевым дренажем [12,35]. У пациентов хирургических стационаров катетер-ассоциированная ИМП в 28% вызвана грибами Candida [41].…”

Section: мочевой дренажunclassified

“…Несмотря на то что другие разновидности Candida ранее встречались менее чем в половине случаев, ряд авторов сообщают о том, что частота выявления в моче штаммов Candida nonalbicans за последние 20 лет выросла и теперь превышает 50% [3]. В последние годы увеличивается частота выявления Cryptococcus, Trichosporon, Geotrichum и других грибковых патогенов [7,[11][12][13]. Возможно, такая тенденция во многом связана с избыточным и неконтролируемым применением противогрибковых препаратов, увеличением числа пациентов с дренажами, увеличением продолжительности жизни и усовершенствованием методов диагностики [6,7].…”

Section: Introductionunclassified

See 1 more Smart Citation

Risk factors of the fungal urinary tract infections

2021

View full text Add to dashboard Cite

The role of fungi as causative agents of infections is growing. In in-patients, especially at intensive care units, fungal infections might cause serious problems. Studies conducted over recent years shows an increase of fungi detection in urine in in-patients from 5,01 up to 10,63%. Most often, the appearance of fungi in the urine connected with contamination or colonization of the urinary tract. However, in immunocompromised patients, this could be the part of urinary tract infection and even of disseminated fungal process. Candida is the most common cause of fungal urinary tract infections. At the same time, the presence of Candida in urine (candiduria) not always comes with clinical signs of urethritis, cystitis and pyelonephritis. Detection of noCandida albicans agents in urine is increasing, new Candida species revealed are resistant to antifungal drugs so risk of complications is increasing. Recent researches reveal new mechanisms of how Candida interacts with the bacteria that cause urinary infections. The main mechanisms of Candida virulence factors are dimorphism, adhesion proteins — Als1-7,9 and Gls, invasion enzymes — phospholipase, Als3 and Ssa1, as well as enzymes that neutralize reactive oxygen species. The most significant risk factors of fungal urinary tract infection are the presence of a urinary catheter, diabetes mellitus, immunosuppression and previous antibiotic intake. The study of the formation process of the cellular and immune response to Candida makes it possible to identify the main links in the pathogenesis of urinary tract candidiasis, as well as the main role of immunosuppression in the development of the disease.

show abstract

“…Candida species are yeasts that form part of skin, genitourinary, and gastrointestinal microbiota. Candida species, most frequently Candida albicans , are responsible for the majority of fungal infections [ 1 , 2 ]. However, non- albicans Candida species are emerging pathogens that may be related to the increased prevalence of fluconazole-resistant species [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Concerning the presumptive identification of Candida kefyr on Uriselect™4 agar

Gómez-Vicente,

Navarro-Marí,

Rodríguez-Guerrero

et al. 2023

Rev Esp Quimioter

View full text Add to dashboard Cite

Introduction. Non-albicans Candida species, such as Candida kefyr, are emerging pathogens. Chromogenic media are highly useful for the diagnosis of urinary tract infections (UTIs). The aim was to describe the behavior of this specie on a non-specific chromogenic medium. Material and methods. A retrospective study of cases of candiduria detected in the Microbiology laboratory of the Virgen de las Nieves Hospital in Granada (Spain) between 2016 and 2021 (N=2,130). Urine samples were quantitatively seeded on non-selective UriSelect™4 chromogenic agar. Results. Between 2016 and 2021, C. kefyr was the seventh most frequent Candida species responsible for candiduria in our setting (n=15). The macroscopic appearance of C. kefyr colonies, punctiform and bluish, allowed the direct identification of these microorganisms. Conclusions. This study provides the first description of the specific behavior of C. kefyr on UriSelect™4 agar, which differentiates it from other Candida species based on its enzymatic characteristics.

show abstract

Arcobacter butzleri and intestinal colonization

Cited by 7 publications

References 16 publications

Actinic cystitis associated with urinary tract infection by Candida glabrata as a differential diagnosis of pudendal neuralgia. Case report

Actinic cystitis associated with urinary tract infection by Candida glabrata as a differential diagnosis of pudendal neuralgia. Case report

Risk factors of the fungal urinary tract infections

Concerning the presumptive identification of Candida kefyr on Uriselect™4 agar

Contact Info

Product

Resources

About